Zeng D - Search Results

1

MCAM/CD146 promotes tamoxifen resistance in breast cancer cells through induction of epithelial-mesenchymal transition, decreased ERα expression and AKT activation.

Liang YK, Zeng D, Xiao YS, Wu Y, Ouyang YX, Chen M, Li YC, Lin HY, Wei XL, Zhang YQ, Kruyt FA, Zhang GJ. Liang YK, et al. Among authors: zeng d. Cancer Lett. 2017 Feb 1;386:65-76. doi: 10.1016/j.canlet.2016.11.004. Epub 2016 Nov 9. Cancer Lett. 2017. PMID: 27838413 Free article.

2

GATA3 and TRPS1 are distinct biomarkers and prognostic factors in breast cancer: database mining for GATA family members in malignancies.

Lin HY, Zeng D, Liang YK, Wei XL, Chen CF. Lin HY, et al. Among authors: zeng d. Oncotarget. 2017 May 23;8(21):34750-34761. doi: 10.18632/oncotarget.16160. Oncotarget. 2017. PMID: 28423734 Free PMC article.

3

Prognostic values of distinct CBX family members in breast cancer.

Liang YK, Lin HY, Chen CF, Zeng D. Liang YK, et al. Among authors: zeng d. Oncotarget. 2017 Sep 28;8(54):92375-92387. doi: 10.18632/oncotarget.21325. eCollection 2017 Nov 3. Oncotarget. 2017. PMID: 29190923 Free PMC article.

4

FoxM1 is a promising candidate target in the treatment of breast cancer.

Lu XF, Zeng D, Liang WQ, Chen CF, Sun SM, Lin HY. Lu XF, et al. Among authors: zeng d. Oncotarget. 2017 Dec 12;9(1):842-852. doi: 10.18632/oncotarget.23182. eCollection 2018 Jan 2. Oncotarget. 2017. PMID: 29416660 Free PMC article.

5

Prognostic values of the inhibitor of DNA‑binding family members in breast cancer.

Zhou XL, Zeng D, Ye YH, Sun SM, Lu XF, Liang WQ, Chen CF, Lin HY. Zhou XL, et al. Among authors: zeng d. Oncol Rep. 2018 Oct;40(4):1897-1906. doi: 10.3892/or.2018.6589. Epub 2018 Jul 23. Oncol Rep. 2018. PMID: 30066902 Free PMC article.

6

Notch3 inhibits epithelial-mesenchymal transition in breast cancer via a novel mechanism, upregulation of GATA-3 expression.

Lin HY, Liang YK, Dou XW, Chen CF, Wei XL, Zeng D, Bai JW, Guo YX, Lin FF, Huang WH, Du CW, Li YC, Chen M, Zhang GJ. Lin HY, et al. Among authors: zeng d. Oncogenesis. 2018 Aug 13;7(8):59. doi: 10.1038/s41389-018-0069-z. Oncogenesis. 2018. PMID: 30100605 Free PMC article.

7

Major vault protein is a direct target of Notch1 signaling and contributes to chemoresistance in triple-negative breast cancer cells.

Xiao YS, Zeng D, Liang YK, Wu Y, Li MF, Qi YZ, Wei XL, Huang WH, Chen M, Zhang GJ. Xiao YS, et al. Among authors: zeng d. Cancer Lett. 2019 Jan;440-441:156-167. doi: 10.1016/j.canlet.2018.09.031. Epub 2018 Oct 15. Cancer Lett. 2019. PMID: 30336197 Free article.

8

Knockdown of nucleophosmin 1 suppresses proliferation of triple-negative breast cancer cells through activating CDH1/Skp2/p27kip1 pathway.

Zeng D, Xiao Y, Zhu J, Peng C, Liang W, Lin H. Zeng D, et al. Cancer Manag Res. 2018 Dec 21;11:143-156. doi: 10.2147/CMAR.S191176. eCollection 2019. Cancer Manag Res. 2018. PMID: 30613163 Free PMC article.

9

Predictive Value of Preoperative Multidetector-Row Computed Tomography for Axillary Lymph Nodes Metastasis in Patients With Breast Cancer.

Chen CF, Zhang YL, Cai ZL, Sun SM, Lu XF, Lin HY, Liang WQ, Yuan MH, Zeng D. Chen CF, et al. Among authors: zeng d. Front Oncol. 2019 Jan 8;8:666. doi: 10.3389/fonc.2018.00666. eCollection 2018. Front Oncol. 2019. PMID: 30671386 Free PMC article.

10

Long noncoding RNA H19 is a critical oncogenic driver and contributes to epithelial-mesenchymal transition in papillary thyroid carcinoma.

Liang WQ, Zeng D, Chen CF, Sun SM, Lu XF, Peng CY, Lin HY. Liang WQ, et al. Among authors: zeng d. Cancer Manag Res. 2019 Mar 6;11:2059-2072. doi: 10.2147/CMAR.S195906. eCollection 2019. Cancer Manag Res. 2019. PMID: 30881130 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,996 results

Search Page

Filters